GEN Once Again on the Fortune 500 Türkiye List!
We are ranked 267th overall and 4th in the Medical and Pharmaceutical industry among Türkiye’s largest companies.
“We are striving to become a GEN that produces and researches more high-value-added drugs in 2025 and beyond,” said our Chairman of the Board, Mr. Abidin Gülmüş, who was featured in the July issue of Fortune Türkiye.
We would like to thank our valuable colleagues, customers, business partners, and investors for their support, trust, and cooperation.
